Biomedical Imaging and Therapy (BMIT-ID)
05ID-2 (POE-2 & SOE-1)

Overview

Status

Commissioning

Source

Superconducting (SC) Wiggler

Energy Range

20 – 100 keV

Wavelength

0.6 – 0.1 Å

Resolution Δ E / E @ E

M1 CT:10-3
M2 CT:10-3
M3 DEI:10-5
M4 KES:10-3

Photon Brightness ( γ /s/0.1%BW) @ 100 mA

3 x 10¹² ph (s * mr² * 0.1%bW * mA) @ 20 keV

Beam Size (Horizontal x Vertical)

220 mm x 11 mm @ 55 m

Description: The BioMedical Imaging and Therapy (BMIT) beamline is designed for the purpose of imaging biological tissue and conducting radiation therapy research. The BMIT facility will address the interest of scientists and clinicians in the diagnosis and treatment of cancer (breast tumours and paediatric oncology), circulatory and respiratory disease (heart disease and asthma) neurological and behavioural disease (brain and spinal cord injuries, epilepsy), reproductive dysfunction (infertility, menopause, and contraceptives), musculo-skeletal disease and kinesiology (arthritis, athletic injuries), and dental conditions (temporomandibular disease).

Endstation(s):

  • Therapy
    a) Custom positioning system. Max. load capacity 136 kg
  • Imaging
    a) Custom positioning system. Max. load capacity 450 kg.

Techniques:

  • Imaging – conventional absorption imaging, DEI / MIR, CT, K-edge Subtraction (KES)
  • Therapy – Microbeam Radiation Therapy, CT Therapy

Optics:

Technical beamline one-pager (PDF)

 

Beamline Webpage


Left to right: Tomasz W. Wysokinski, Denise Miller, Dean Chapman, George Belev

Contacts

Beamline Scientist: Tomasz W. Wysokinski (306) 657-3710

Beamline Team Leader: Dean Chapman

Beamline Telephone: (306) 657-3500

 

Last modified: 2010-05-26 14:05:12

Canadian Light Source